ArticleClinical proteomics2017

A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption.

Regent Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.